red blood cells autotransfusion

PreclinicalBiologic

red blood cells autotransfusion is one of 5 biologic programs targeting Epidural Analgesia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Epidural AnalgesiaCompleted

Epidural AnalgesiaPreclinical

Completed

Competition

Competitive Landscape

7 competitors in Epidural Analgesia

#DrugCompanyPhaseTrials

Intrathecal Morphine

Pacira Pharmaceuticals, Inc

Phase 3

3 2

EXPAREL

Pacira Pharmaceuticals, Inc

Preclinical

1 3

Bupivicaine

TThomas Jefferson University

Preclinical

1 4

red blood cells autotransfusion

MMichał Stasiowski

Preclinical

1 5

Dexmedetomidine Perineurally

ZZealand University Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Epidural Analgesia1 trial

AoA Guided Thoracic Epidural Analgesia for Abdominal Aortic Repair

Completed·MMichał Stasiowski·N/A·NCT06609993·75 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for red blood cells autotransfusion. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — red blood cells autotransfusion compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for red blood cells autotransfusion. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Michał Stasiowski company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: MMichał Stasiowski

red blood cells autotransfusion

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Epidural Analgesia1 trial

References

Drug Info

Quick Facts

Related News